(Q38055261)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23095103%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

title

Anticoagulation in atrial fibrillation and co-existent chronic kidney disease: efficacy versus safety (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23095103%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

chronic renal insufficiency

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23095103%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Amar M Salam

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23095103%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1

Imtiaz Salim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23095103%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

3

Wissam Ghadban

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23095103%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

language of work or name

English

0 references

publication date

24 October 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23095103%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Drug Safety

16 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23095103%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23095103%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23095103%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

53-63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23095103%20AND%20SRC:MED&resulttype=core&format=json

Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy

16 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Atrial fibrillation in incident dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The fiamingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Elevated risk of stroke among patients with end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Hypercoagulability in chronic kidney disease is associated with coagulation activation but not endothelial function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Impact of decreased renal function on coagulation and fibrinolysis in patients with non-valvular atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Relation of baseline presence and severity of renal disease to long-term mortality in persons with known stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Decreased glomerular filtration rate is a risk factor for hemorrhagic but not for ischemic stroke: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Incidence of stroke among chronic hemodialysis patients with nonrheumatic atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Validation of Clinical Classification Schemes for Predicting Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Intima-media thickness of the carotid artery and its correlation factors in maintenance hemodialysis patients: a cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Cardiovascular disease on hemodialysis: predictors of atherosclerosis and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Atrial fibrillation in chronic dialysis patients in the United States: risk factors for hospitalization and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Warfarin anticoagulation in hemodialysis patients: a systematic review of bleeding rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Dilemmas in the management of atrial fibrillation in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Vitamin K-dependent proteins, warfarin, and vascular calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Vascular calcification: the price to pay for anticoagulation therapy with vitamin K-antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Stroke in patients on maintenance hemodialysis: a 22-year single-center study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Warfarin dosing in patients with impaired kidney function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

The new oral anticoagulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

New antithrombotics for atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Pharmacokinetics and pharmacodynamics of the new oral anticoagulants dabigatran and rivaroxaban

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Drug and dietary interactions of warfarin and novel oral anticoagulants: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Dabigatran versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Increased thromboxane biosynthesis in patients with acute cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Urinary 11-dehydro-thromboxane B(2) and coagulation activation markers measured within 24 h of human acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Urinary thromboxane A2 metabolites in patients presenting in the emergency room with acute chest pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Dabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Apixaban versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Apixaban in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Should hemodialysis patients with atrial fibrillation undergo systemic anticoagulation? A cost-utility analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

Clinical Features and Neurologic Severity in Stroke Patients with Mild to Moderate Renal Dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.732569

10.1517/14740338.2013.732569

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23095103%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference